European Archives - Page 2 of 1301 - European Medical Journal

smoking

Even Low Levels of Smoking Linked to Heart Disease

New research reveals that low intensity smoking still drives major cardiovascular risks. Find out what the data shows.

BMI

BMI Not Linked to Distal Interphalangeal Joint Osteoarthritis in Rheumatoid Arthritis

Study finds body mass index does not affect incidence or progression of distal interphalangeal joint osteoarthritis in rheumatoid arthritis patients.

Menopause

Women Largely Uninformed About Menopause

Most women lack essential knowledge about menopause, a new UCL study finds.

Sorfequiline Shows Promise in Shortened Tuberculosis Therapy

Sorfequiline, combined with pretomanid and linezolid, shows superior efficacy and safety in drug-sensitive TB, supporting its potential role in ultra-short treatment regimens.

familial hypercholesterolemia

Hundreds Unknowingly Carry Familial Hypercholesterolemia Gene

A large USA study found hundreds of undiagnosed familial hypercholesterolemia cases through genetic sequencing, showing clinical tests often miss this treatable risk.

Lupus-like Disease

Lupus-like Disease Linked to MDS/CMML May Require Clone-Directed Therapy

Lupus-like disease linked to MDS/CMML shows distinct features and poor response to standard treatment, improving with clone-directed therapy.

Mitigating the Treatment Gap in Drug-Resistant Epilepsy

This video presents an interview with epilepsy expert Ahmed Abdelmoity, discussing the current treatment landscape for patients with drug…

HIV: The Next Chapter

In this series, host Catherine Glass speaks with Jürgen Rockstroh about the evolving landscape of HIV care in Europe. From treatment…

Five Year Data for Transcatheter Mitral Valve Replacement - EMJ

Transcatheter Mitral Valve Replacement: Five-Year Outcomes

New five-year study results highlight durable outcomes and symptom improvement after transcatheter mitral valve replacement therapy.

Hanna Svanbäck

Hanna Svanbäck on shaping the future of Alzheimer’s care

Isabel is joined by Hanna Svanbäck, Executive Director for Neuroscience, Eli Lilly, for a deep dive into the current and future Alzheimer’s landscape.